1. Home
  2. Indian Stocks
  3. Top Pharma Companies in India

Top Pharma Companies in India

Sensex 59932.24
224.16 (0.38%)
Screens:
5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×
×
×
Filter Place order

Top Pharma Companies in India as on Feb-2023


 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter Place order
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
  1. Sun Pharmaceutical Industries Ltd.
    2,43,329
    (Large Cap)
    1008.00
    (-0.61%)
    57.42
    4.37
    4.31
    -0.26
    Q V PT
  2. Divis Laboratories Ltd.
    89,087
    (Large Cap)
    3267.15
    (-2.64%)
    29.03
    7.16
    17.13
    21.96
    Q V PT
  3. Cipla Ltd.
    83,321
    (Large Cap)
    1024.95
    (-0.71%)
    31.36
    3.65
    8.62
    22.70
    Q V+ PT
  4. Dr. Reddys Laboratories Ltd.
    72,446
    (Large Cap)
    4370.05
    (0.45%)
    19.95
    3.3
    8.70
    8.70
    Q V PT
  5. Apollo Hospitals Enterprise Ltd.
    61,369
    (Large Cap)
    4233.00
    (-0.82%)
    64.99
    9.31
    -0.65
    14.27
    Q V+ PT
  6. Torrent Pharmaceuticals Ltd.
    51,907
    (Large Cap)
    1540.70
    (0.46%)
    62.77
    8.18
    7.91
    4.19
    Q V PT
  7. Zydus Lifesciences Ltd.
    44,092
    (Large Cap)
    432.60
    (-0.69%)
    22.59
    2.63
    10.24
    8.02
    Q V PT
  8. Abbott India Ltd.
    43,983
    (Large Cap)
    20484.15
    (-1.04%)
    49.36
    16.04
    11.13
    23.40
    Q V+ PT
  9. Max Healthcare Institute Ltd.
    42,853
    (Large Cap)
    440.40
    (-0.23%)
    67.63
    6.36
    0.00
    124.35
    Q V+ PT
  10. Alkem Laboratories Ltd.
    36,265
    (Large Cap)
    3074.60
    (1.37%)
    36.59
    4
    14.19
    11.50
    Q V PT
  11. Lupin Ltd.
    33,492
    (Large Cap)
    741.85
    (0.75%)
    495.63
    2.85
    0.00
    -190.23
    Q V PT
  12. Biocon Ltd.
    28,784
    (Large Cap)
    239.15
    (-0.25%)
    26.93
    3.18
    0.00
    -32.55
    Q V PT
  13. Aurobindo Pharma Ltd.
    24,173
    (Large Cap)
    409.90
    (-0.64%)
    18.08
    1.4
    3.28
    -3.37
    Q V PT
  14. Syngene International Ltd.
    22,775
    (Large Cap)
    562.40
    (-0.87%)
    52.36
    6.69
    16.72
    6.62
    Q V PT
  15. Ipca Laboratories Ltd.
    21,655
    (Large Cap)
    856.50
    (0.35%)
    33.94
    3.72
    11.59
    37.95
    Q V PT
  16. Gland Pharma Ltd.
    20,801
    (Large Cap)
    1275.95
    (1.02%)
    21.39
    2.67
    24.37
    -23.00
    Q V+ PT
  17. Fortis Healthcare Ltd.
    20,984
    (Large Cap)
    278.30
    (0.13%)
    355.57
    2.35
    0.00
    0.00
    Q V PT
  18. Glaxosmithkline Pharmaceuticals Ltd.
    21,188
    (Large Cap)
    1235.45
    (-1.22%)
    12.41
    14.35
    2.42
    3.56
    Q V PT
  19. Laurus Labs Ltd.
    18,021
    (Mid Cap)
    338.80
    (1.27%)
    19.89
    4.6
    20.98
    35.95
    Q V PT
  20. Pfizer Ltd.
    17,434
    (Mid Cap)
    3853.05
    (1.10%)
    28.74
    6.04
    5.84
    20.34
    Q V PT
  21. Dr. Lal Pathlabs Ltd.
    17,110
    (Mid Cap)
    2019.90
    (-1.60%)
    58.91
    10.88
    16.26
    17.77
    Q V PT
  22. JB Chemicals & Pharmaceuticals Ltd.
    15,651
    (Mid Cap)
    2040.95
    (0.88%)
    44.31
    6.94
    12.81
    20.13
    Q V+ PT
  23. Ajanta Pharma Ltd.
    15,171
    (Mid Cap)
    1189.55
    (0.46%)
    24.66
    4.07
    10.99
    6.09
    Q V PT
  24. Narayana Hrudayalaya Ltd.
    14,559
    (Mid Cap)
    721.50
    (1.28%)
    33.06
    8.19
    14.53
    32.55
    Q V PT
  25. Sanofi India Ltd.
    12,535
    (Mid Cap)
    5416.85
    (-0.47%)
    21.51
    7.87
    5.76
    14.09
    Q V PT
  26. Suven Pharmaceuticals Ltd.
    12,520
    (Mid Cap)
    488.20
    (-0.73%)
    28.81
    8.27
    0.00
    0.00
    Q V PT
  27. Krishna Institute of Medical Sciences Ltd
    11,613
    (Mid Cap)
    1441.25
    (-0.68%)
    47.23
    7.73
    16.37
    0.00
    Q V PT
  28. Glenmark Pharmaceuticals Ltd.
    10,797
    (Mid Cap)
    389.25
    (1.72%)
    13.23
    1.15
    6.27
    -2.52
    Q V PT
  29. Alembic Pharmaceuticals Ltd.
    10,614
    (Mid Cap)
    540.20
    (0.04%)
    47.36
    2.03
    11.10
    2.80
    Q V PT
  30. Aster DM Healthcare Ltd.
    10,450
    (Mid Cap)
    208.60
    (-0.29%)
    21.38
    2.52
    11.57
    0.00
    Q V PT
First Previous 1

Check out the List of Undervalued Pharma Stocks

Pharma sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical companies even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma companies:

News about Top Pharma Companies in India

Ajanta Pharma reports 30% fall in Q3 consolidated net profit

Total consolidated income of the company increased by 16.79% to Rs 1,006.70 crore for Q3FY23
02 Feb, 2023

Alembic Pharmaceuticals reports 29% fall in Q3 consolidated net profit

Total consolidated income of the company increased by 17.29% to Rs 1,509.46 crore for Q3FY23
02 Feb, 2023

Biocon offloads 10% stake in Syngene International

The shares were sold at an average price of Rs 560 apiece, taking the transaction value at Rs 2,240 crore
02 Feb, 2023

Alembic Pharmaceuticals informs about details of loss of certificate

Alembic Pharmaceuticals has informed that it enclosed the intimation dated 1st February, 2023 received from Link lntime India, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).

The above information is a part of company’s filings submitted to BSE.

01 Feb, 2023

Alembic Pharma - Quaterly Results

The Revenue for the quarter ended  December 2022 of Rs. 13102.10 millions grew by 5.84 % from Rs. 12379.50 millions.The Net Profit of the company slipped to Rs. 1191.30 millions from Rs. 1768.00 millions, a decline of -32.62% on QoQ basis.The company reported a degrowth in operating Profit to 2248.10 millions from 2743.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 13102.10 12379.50 5.84 38249.60 37093.50 3.12 49966.00 50514.40 -1.09
Other Income 5.90 153.10 -96.15 16.70 390.80 -95.73 499.80 835.20 -40.16
PBIDT 2248.10 2743.50 -18.06 5978.20 7882.80 -24.16 11044.30 15819.70 -30.19
Interest 146.50 43.90 233.71 353.10 109.30 223.06 166.70 127.70 30.54
PBDT 2101.60 2699.60 -22.15 5625.10 7773.50 -27.64 10877.60 15692.00 -30.68
Depreciation 658.50 557.10 18.20 1787.40 1534.20 16.50 1793.10 1526.00 17.50
PBT 1443.10 2142.50 -32.64 3837.70 6239.30 -38.49 9084.50 14166.00 -35.87
TAX 251.80 374.50 -32.76 457.40 1113.10 -58.91 1144.50 2412.10 -52.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1191.30 1768.00 -32.62 3380.30 5126.20 -34.06 7940.00 11753.90 -32.45
Equity 393.10 393.10 0.00 393.10 393.10 0.00 393.10 393.10 0.00
PBIDTM(%) 17.16 22.16 -22.58 15.63 21.25 -26.45 22.10 31.32 -29.42
01 Feb, 2023

Ajanta Pharma - Quaterly Results

The revenue zoomed 8.20% to Rs. 8748.90 millions for the quarter ended December 2022 as compared to Rs. 8085.80 millions during the corresponding quarter last year.The Company to register a -36.34%  fall in the net profit for the quarter ended December 2022.Operating Profit reported a sharp decline to 1899.20 millions from 2657.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 8748.90 8085.80 8.20 25624.10 23750.10 7.89 31406.40 27185.90 15.52
Other Income 305.10 279.00 9.35 1443.00 1113.10 29.64 1397.30 1035.70 34.91
PBIDT 1899.20 2657.70 -28.54 6507.50 8150.50 -20.16 10306.20 10204.80 0.99
Interest 26.80 7.00 282.86 40.20 19.40 107.22 91.20 69.00 32.17
PBDT 1872.40 2650.70 -29.36 6467.30 8131.10 -20.46 10215.00 10135.80 0.78
Depreciation 322.90 307.10 5.14 948.40 908.70 4.37 1209.60 1114.90 8.49
PBT 1549.50 2343.60 -33.88 5518.90 7222.40 -23.59 9005.40 9020.90 -0.17
TAX 309.90 396.50 -21.84 1103.80 1372.20 -19.56 1806.80 2264.50 -20.21
Deferred Tax 134.60 66.60 102.10 55.20 130.00 -57.54 95.10 97.70 -2.66
PAT 1239.60 1947.10 -36.34 4415.10 5850.20 -24.53 7198.60 6756.40 6.54
Equity 257.10 173.90 47.84 257.10 173.90 47.84 171.70 173.90 -1.27
PBIDTM(%) 21.71 32.87 -33.96 25.40 34.32 -26.00 32.82 37.54 -12.58
01 Feb, 2023

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical companies in India by Market Capitalization as of 2023.
Rank Company Market Capitalization 2023 (INR  crores)
1 Sun Pharmaceutical Industries Ltd. 2,43,329 Crore
2 Divis Laboratories Ltd. 89,087 Crore
3 Cipla Ltd. 83,321 Crore
4 Dr. Reddys Laboratories Ltd. 72,446 Crore
5 Apollo Hospitals Enterprise Ltd. 61,369 Crore
6 Torrent Pharmaceuticals Ltd. 51,907 Crore
7 Zydus Lifesciences Ltd. 44,092 Crore
8 Abbott India Ltd. 43,983 Crore
9 Max Healthcare Institute Ltd. 42,853 Crore
10 Alkem Laboratories Ltd. 36,265 Crore
Find best pharma companies to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best companies to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Abbott India Ltd. (L) Very Good 20,484 43,983 49.88 16.20 37.77 29.57
Divis Laboratories Ltd. (L) Very Good 3,267 89,087 29.77 7.34 22.22 27.91
Laurus Labs Ltd. (M) Very Good 338.8 18,021 19.64 4.54 13.82 27.60
Pfizer Ltd. (M) Very Good 3,853 17,434 28.43 5.98 18.87 23.21
Sanofi India Ltd. (M) Very Good 5,417 12,535 21.61 7.91 22.46 22.31

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Abbott India Ltd. (L) Very Good 20,484 43,983 26.35
Sun Pharmaceutical Industries Ltd. (L) Very Good 1,008 2,43,329 13.37
Torrent Pharmaceuticals Ltd. (L) Very Good 1,541 51,907 12.63
Cipla Ltd. (L) Very Good 1,025 83,321 7.72
Zydus Lifesciences Ltd. (L) Very Good 432.6 44,092 4.37
View More

To select the best stocks from the Nifty Pharma, you can check factors like stock returns over different time frames, the Return on Equity, the Price to Earnings (P/E) ratio, Price to Book Value (P/BV) ratio, and the company’s profitability.

Companies that have performed well fundamentally are more likely to see their stock prices gain too.

Nifty Pharma Stocks with the highest revenue growth in the past five years is :

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Gland Pharma Ltd. (L) Very Good 1,276 20,801 21.17 2.64 11.63 24.37
Laurus Labs Ltd. (M) Very Good 338.8 18,021 19.64 4.54 13.82 20.98
Granules India Ltd. (M) Somewhat Good 289.1 7,051 14.02 2.72 11.82 19.13
Divis Laboratories Ltd. (L) Very Good 3,267 89,087 29.77 7.34 22.22 17.13
Alkem Laboratories Ltd. (L) Very Good 3,075 36,265 36.09 3.95 19.92 14.19

Companies with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Nifty Pharma companies that had the highest profit growth in the past five years is :

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Ipca Laboratories Ltd. (L) Very Good 856.5 21,655 33.83 3.71 16.99 37.95
Laurus Labs Ltd. (M) Very Good 338.8 18,021 19.64 4.54 13.82 35.95
Abbott India Ltd. (L) Very Good 20,484 43,983 49.88 16.20 37.77 23.40
Cipla Ltd. (L) Very Good 1,025 83,321 31.57 3.67 17.74 22.70
Divis Laboratories Ltd. (L) Very Good 3,267 89,087 29.77 7.34 22.22 21.96
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | PML Act | Grievance Redressal Process | Investor charter
© 2023 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.